Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study

By afschroeder • September 9, 2025

Kaczorowski-Worthley A, Mudaranthakam DP, Reichuber J, Streiler C, Pandya S, Boente R, Mathai SK, Adegunsoye A, Swigris J, Volkmann ER, Solomon JJ, England BR, Matson SM. Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study. CHEST Pulm. 2025 Jun;3(2):100159. doi: 10.1016/j.chpulm.2025.100159. Epub 2025 Mar 24. PMID: 40918540; PMCID: PMC12410752.

Tags: Antifibrotics, interstitial lung disease, Pragmatic trial, Publications, rheumatoid arthritis interstitial lung disease, Rheumatology

Mucus plugs in chronic obstructive pulmonary disease are heterogeneous in size and shape and occur in relatively large airways

Farooqui ON, Elicker BM, Henry TS, Hahn LD, Kallianos KG, Han MK, Barr RG, Smith BM, Comellas AP, Bon J, Hansel N, Wells JM, Paine[...]

Measures of Vascular Volume in the Lung: An Emerging Quantitative Tool for Clinical and Physiological Studies in Pulmonary Vascular Disease

Rahaghi FN. Measures of Vascular Volume in the Lung: An Emerging Quantitative Tool for Clinical and Physiological Studies in Pulmonary Vascular Disease. Am J Respir[...]

Genomic surveillance of human metapneumovirus in the United States, 2010-2025

Bendall EE, Fitzsimmons WJ, Valvano WD, Truscon R, Self WH, Halasa N, Chappell JD, Zhu Y, Safdar B, Ginde AA, Peltan ID, Gaglani M, Columbus[...]